Quattrii DPI Platform Redefines Inhaler Delivery
The Quattrii dry powder inhaler, developed by CHI and commercialized with Aptar Pharma, promises high-dose accuracy, less cough, and deeper lung reach.
The Quattrii dry powder inhaler, developed by CHI and commercialized with Aptar Pharma, promises high-dose accuracy, less cough, and deeper lung reach...